2[2]Carrozza JP, Kuntz RE, Levine MJ, et al Amgiographic and clinical outcome of intracoronary stentign:Immediated and longterm results from a large single-center experience. J Am Coil Cardiol, 1992;20:38～337
3[3]Okumura K,Yasue H, Matsuyamak, et al. Effect of acetylocloline on the highly stenotic coronary artery: difference beteen the constrictor response of the infarct - related coronary artery and that of the noninfarct-related artery. J Am Coll Cardiol, 1992;19:752
4[4]Yanagiswa M, Massaki T, Schenke WH, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature , 1988;332:411
5[5]Enrico H, Pasguals A, Maria D, et al. Plasma endothelin-1 levels in patients with angina pectoris and normal coronary angiograms. J Am Heart J,1998;135: 684
6[6]John M. Rohn of angiotensin-convertion enzyme inhibition in reversal of endothelial dysfunction in coronary artery disease.Am J Med, 1998;105[A]:405
7[7]Ludmer PL, Selwyn AP, shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries.N Engl J Med, 1986;325:1046
8[8]Celrmajer DS, Sorensen KE, Gooch VM, et al .Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet,1992;340(8828):1111～1115
9[9]Anderson TJ, Uehata A, Gerbard MD, et al, Close relation of endothelial function in the human coronary and peripheral circulations, J Am Coil Cardiol, 1995;26:1235
10[10]Cannon RO, Schenke WH, Quyyumi A, et al. Comparision of exercise testing with studies of coronary flow reserve in patients with microvascular angina. Circulation, 1991;8315 Supple :Ⅲ77～81
9Downs J R, Clearfield M, Whitney E, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA, 1998, 279(20): 1659-1661
10Valgimigli M, Merli E, Malagutti P, et al. Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress.Arch Biochem Biophys,2003,420(2): 255-261
